SCHEDULE 13G/A//SEC Filing
Lyell Immunopharma, Inc. SCHEDULE 13G/A
Accession 0001104659-25-112479
CIK 0001704131other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:05 PM ET
Size
22.8 KB
Accession
0001104659-25-112479
Documents
Issuer
Foresite Capital Fund IV, L.P.
CIK 0001704131
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001704131
Filing Metadata
- Form type
- SCHEDULE 13G/A
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:05 PM ET
- Size
- 22.8 KB